首页> 外国专利> CARBAMATE ESTERS OF ESEROLINE HAVING ANTICHOLINESTERASE ACTIVITY, A PROCESS FOR THEIR PREPARATION AND RELATIVE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS THE ACTIVE PRINCIPLE

CARBAMATE ESTERS OF ESEROLINE HAVING ANTICHOLINESTERASE ACTIVITY, A PROCESS FOR THEIR PREPARATION AND RELATIVE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS THE ACTIVE PRINCIPLE

机译:具有抗胆碱酯酶活性的异戊二烯的氨基甲酸酯类化合物,其制备方法及相关药物成分(作为活性成分)

摘要

Carbamate esters of eseroline having anticholinesterase activity characterized by the following formula (I): wherein W is a substituent, as defined in the following Specification, HY is a pharmaceutically acceptable organic or inorganic acid x may be 0, 1, 2 and 3 in case of monofunctional acids provided that x is 3 only when W is or 1/2 and 1/3 in case of bifunctional or trifunctional acids, a process for their preparation and pharmaceutical compositions containing said compounds , as the active principles, for the treatment of diseases associated with cholinergic disorders.
机译:具有抗胆碱酯酶活性的五羟色胺的氨基甲酸酯,其特征在于下式(I):其中W是取代基,如以下说明书中所定义,HY是药学上可接受的有机或无机酸,在情况下,x可以是0、1、2和3 ,前提是x仅在W为或在双官能或三官能酸的情况下为1/2和1/3时为3,其制备方法和包含所述化合物作为活性成分的药物组合物用于治疗疾病与胆碱能障碍有关。

著录项

  • 公开/公告号CA2068501A1

    专利类型

  • 公开/公告日1992-11-14

    原文格式PDF

  • 申请/专利权人 MAGIS FARMACEUTICI;

    申请/专利号CA19922068501

  • 发明设计人 PURICELLI LAURA;

    申请日1992-05-12

  • 分类号C07D487/04;A61K31/40;A61K31/675;C07F9/6561;

  • 国家 CA

  • 入库时间 2022-08-22 05:08:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号